Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of oral vasopressor therapies for postoperative hypotension
ACTRN12624000342516Phase 3Completed
- Sponsor
- Royal Melbourne Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative hypotension comparing Midodrine, Atomoxetine and Placebo (3 arms). Primary endpoint: Minimum recruitment rate per week. Started Feb 2025; status: completed.
02
Drugs
midodrineatomoxetine
03
Conditions
postoperative hypotension
Beyond the preview
Go deeper on ACTRN12624000342516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000342516.